April 9 (Reuters) - Microbot Medical Inc MBOT.O:
MICROBOT MEDICAL® SHARES RESULTS FROM ITS PIVOTAL CLINICAL TRIAL, ACHIEVING 100% ROBOTIC NAVIGATION SUCCESS FOR THE LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM
MICROBOT MEDICAL INC - LIBERTY(®) SHOWED A 92% REDUCTION IN RADIATION EXPOSURE WITH NO ADVERSE EVENTS REPORTED
MICROBOT MEDICAL INC - SUCCESSFUL ROBOTIC NAVIGATION WAS ACHIEVED IN EVERY CASE AND MET PRIMARY ENDPOINT OF STUDY
Source text: ID:nGNXbck9Lg
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))